Vaccination against COVID-19 for patients with chronic kidney disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enroll patients receiving dialysis or those who have undergone kidney transplantation to assess their response to COVID-19 vaccination. Given the increased risk of severe illness from COVID-19 in these populations, the study will analyze the effectiveness of the vaccine in immunocompromised individuals. By monitoring vaccine responses in clinical practice, the study seeks to provide insights into how to better protect these patients against COVID-19. The findings could help inform future vaccination strategies for patients with chronic kidney disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* receiving dialysis (hemodialysis or peritoneal dialysis)
* capable of giving consent
* age 18 or older

Exclusion Criteria:

- non-capable of giving consent

Where it's running

• MVZ DaVita Rhein-Ruhr
  Düsseldorf, Germany Recruiting
• KfH Kuratorium für Dialyse und Nierentransplantation e.V.
  Düsseldorf, Germany Recruiting
• University Hospital Düsseldorf, Heinrich Heine University
  Düsseldorf, Germany Recruiting
• Nephrocare Mettmann
  Mettmann, Germany Recruiting
• Hospital Solingen
  Solingen, Germany Recruiting

Study contacts

• Study coordinator: Johannes Stegbauer, MD
• Email: johannes.stegbauer@med.uni-duesseldorf.de
• Phone: +492118117502

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing vaccine responses in kidney transplant patients and their healthy cohabitants

  This study is testing how well the shingles vaccine works in kidney transplant patients on different medications compared to their healthy family members.

  Recruiting Central Adelaide Local Health Network Incorporated · Adelaide, South Australia · NCT06262776

• Examining how antibiotics affect immune responses to vaccines

  This study tests how taking antibiotics affects the immune response to vaccines in healthy adults aged 18-35.

  Recruiting Phase 4 South Australian Health and Medical Research Institute · Adelaide, South Australia · NCT06148025

• Evaluating the Benefits of a Third MMRV Vaccine Dose for Adults in Alberta

  This study is trying to see if giving a third dose of the MMRV vaccine can boost the immune response in women who didn't have strong enough protection after their first two doses.

  Recruiting University of Alberta · Edmonton, Alberta · NCT05923970

• Pumpkin seed oil for people on hemodialysis

  This study tests whether taking pumpkin seed oil daily for 3 months helps reduce inflammation and improve-related lab markers in people with end-stage kidney disease on dialysis.

  Recruiting Al-Mustansiriyah University · Baghdad, Karkh · NCT07710183

• How dialysis affects sexual function and intimacy

  This project will see how dialysis affects sexual health and intimacy in adults who have been on hemodialysis or peritoneal dialysis for at least six months.

  Recruiting CMC Ambroise Paré · Neuilly-sur-Seine, Île-de-France Region · NCT07332949

• Using body composition and kidney function measurements to assess nutrition in hemodialysis patients

  This study is testing if using body composition and kidney function measurements can help better understand the nutrition of people on hemodialysis.

  Recruiting University of Tartu · Tartu, Tartu · NCT06873880

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.